QuikChange Multi Site-Directed Mutagenesis Kit - Commercial, 30 Rxn
Agilent TechnologiesThe original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
The original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
The original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
The original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
The original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
The original QuikChange Site-Directed Mutagenesis Kits eliminate the need for subcloning into M13-based bacteriophage vectors and for ss-DNA rescue.
Simple, Non-Toxic Methods Deliver Pure Genomic DNA
Simple, Non-Toxic Methods Deliver Pure Genomic DNA
The StrataClone PCR Cloning Kit allows high-efficiency, 5-minute cloning of PCR products at room temperature, using the efficient DNA rejoining activity of DNA topoisomerase I and the DNA recombination activity of Cre recombinase.
The StrataClone PCR Cloning Kit allows high-efficiency, 5-minute cloning of PCR products at room temperature, using the efficient DNA rejoining activity of DNA topoisomerase I and the DNA recombination activity of Cre recombinase.
Agilent's RNA Isolation Kits provide a straightforward, spin-column method to deliver RNA for use in gene expression and other downstream analyses.
Highest efficiency competent cells in convenient packaging designed to satisfy higher throughput requirements. For ultimate convenience we offer custom configurations, formulations, and packaging options. Visit our custom & bulk services page, or contact your local sales specialist.
The AAV Helper-Free System eliminates the requirement for wild-type adenovirus co-infection from both AAV vector production and AAV stock titering steps, making this system entirely helper virus-free and safer.
The AAV Helper-Free System eliminates the requirement for wild-type adenovirus co-infection from both AAV vector production and AAV stock titering steps, making this system entirely helper virus-free and safer.
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold.
The AdEasy system saves you a month of work over traditional methods by producing the recombinant adenoviral plasmid by homologous recombination in E. coli.
ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.
In addition to enhancing protein solubility, we have combined our cold-adapted technology with our premiere BL21-CodonPlus competent cells to further increase your chances of protein expression success.
In addition to enhancing protein solubility, we have combined our cold-adapted technology with our premiere BL21-CodonPlus competent cells to further increase your chances of protein expression success.
ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.
In addition to enhancing protein solubility, we have combined our cold-adapted technology with our premiere BL21-CodonPlus competent cells to further increase your chances of protein expression success.
In addition to enhancing protein solubility, we have combined our cold-adapted technology with our premiere BL21-CodonPlus competent cells to further increase your chances of protein expression success.